Market By Products, Applications, End-users And Geography | Forecast 2019-2027
Triton Market Research has concluded that the Latin America immunohistochemistry market is projected to grow with a CAGR of 6.85% in the estimated years 2019-2027.
The immunohistochemistry report on the Latin American region includes the countries of:
• Brazil
• Mexico
• Argentina
• Chile
• Cuba
• Rest of Latin America
To get detailed insights on segments, Download Sample Report
Brazil has a noteworthy portion of quality hospitals in Latin America and draws in patients from neighboring countries, mostly for cardiovascular treatment, cancer and plastic surgery. The geriatric population in Brazil is also increasing, which is expected to result in increased healthcare expenditure due to an increase in age-related diseases. Statistics from the National Center for Biotechnology Information (NCBI) suggest cancer to be the second most common cause of death in Brazil after cardiac and cerebrovascular diseases. This trend is expected to result in an increase in demand for tissue diagnostics for the treatment and management of such diseases, thereby positively impacting the immunohistochemistry market in Brazil. The rise in the prevalence of chronic diseases in Cuba has led to an increased demand for IHC reagents, antibodies and diagnostic procedure equipment in hospitals and diagnostic laboratories in Cuba.
The rise in prevalence of chronic diseases in Mexico has led to an increased demand for IHC antibodies, reagents and diagnostic procedures equipment in diagnostic laboratories and hospitals in Mexico. The immunohistochemistry market is expected to observe significant growth in Chile, as a result of a rapidly aging population and increasing prevalence of cancer & other lifestyle diseases such as obesity & other chronic conditions that require tissue diagnostics for detection and treatment. Healthcare expenditure is increasing with the increase in geriatric population and increasing prevalence of diseases. This increase is expected to be from the increased demand for healthcare services owing to the increasing aging populace and the rising prevalence of diseases like cancer. Therefore, increasing healthcare expenditure is expected to have a positive impact on the immunohistochemistry market in Chile.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA IMMUNOHISTOCHEMISTRY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. HISTORY
OF IMMUNOHISTOCHEMISTRY
2.2. VALUE
CHAIN OUTLOOK
2.3. KEY
INSIGHTS
2.4. MARKET
ATTRACTIVENESS MATRIX
2.5. MARKET
DRIVERS
2.5.1. IN-VITRO
TECHNOLOGICAL ADVANCEMENTS
2.5.2. INCREASING
CANCER OCCURRENCE
2.5.3. SWELLING
HEALTHCARE SPENDING
2.5.4. RISING
GERIATRIC POPULATION
2.5.5. INCREASING
USE OF POC TESTING
2.6. MARKET
RESTRAINTS
2.6.1. RESTRICTIONS
OF CLOSED SYSTEMS
2.6.2. REIMBURSEMENT
ISSUES
2.7. MARKET
OPPORTUNITIES
2.7.1. INCREASING
USE OF BIOMARKERS FOR DISEASE DIAGNOSIS
2.7.2. TECHNOLOGICAL
ADVANCEMENTS
2.8. MARKET
CHALLENGES
2.8.1. STRINGENT
REGULATIONS
2.8.2. HIGH
MAINTENANCE COST INFLUENCING THE MARKET GROWTH
3. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY PRODUCTS
3.1. ANTIBODIES
3.1.1. PRIMARY
ANTIBODIES
3.1.2. SECONDARY
ANTIBODIES
3.2. EQUIPMENT
3.2.1. SLIDE
STAINING SYSTEMS
3.2.2. TISSUE
MICROARRAYS
3.2.3. TISSUE
PROCESSING SYSTEMS
3.2.4. SLIDE
SCANNERS
3.2.5. OTHER
EQUIPMENT
3.3. REAGENTS
3.3.1. HISTOLOGICAL
STAINS
3.3.2. BLOCKING
SERA AND REAGENTS
3.3.3. CHROMOGENIC
SUBSTRATES
3.3.4. FIXATION
REAGENTS
3.3.5. STABILIZERS
3.3.6. ORGANIC
SOLVENTS
3.3.7. PROTEOLYTIC
ENZYMES
3.3.8. DILUENTS
3.4. KITS
4. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY APPLICATIONS
4.1. DIAGNOSTICS
4.1.1. CANCER
4.1.2. INFECTIOUS
DISEASES
4.1.3. CARDIOVASCULAR
DISEASE
4.1.4. AUTOIMMUNE
DISEASES
4.1.5. DIABETES
MELLITUS
4.1.6. NEPHROLOGICAL
DISEASES
4.2. DRUG
TESTING
5. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY END-USERS
5.1. HOSPITALS
AND DIAGNOSTIC LABORATORIES
5.2. RESEARCH
INSTITUTES
5.3. OTHER
END-USERS
6. IMMUNOHISTOCHEMISTRY
(IHC) MARKET - LATIN AMERICA
6.1. COUNTRY
ANALYSIS
6.1.1. BRAZIL
6.1.2. MEXICO
6.1.3. ARGENTINA
6.1.4. CHILE
6.1.5. CUBA
6.1.6. REST
OF LATIN AMERICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. ABCAM
PLC
7.3. AGILENT
TECHNOLOGIES, INC.
7.4. BIOGENEX
7.5. BIO-RAD
LABORATORIES, INC.
7.6. BIO
SB
7.7. CELL
SIGNALING TECHNOLOGY, INC.
7.8. DANAHER
CORPORATION
7.9. F.
HOFFMANN-LA ROCHE AG
7.10.
HISTOLOGIX
7.11.
MERCK MILLIPORE
7.12.
PERKINELMER, INC.
7.13.
SIEMENS AG HEALTHCARE
7.14.
THERMO FISHER SCIENTIFIC, INC.
8. METHODOLOGY
AND SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1 LATIN AMERICA MARKET FOR
IMMUNOHISTOCHEMISTRY BY REGION 2019-2027 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND
TREATMENT
TABLE 3 LATIN AMERICA IMMUNOHISTOCHEMISTRY
MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 4 LATIN AMERICA IMMUNOHISTOCHEMISTRY
MARKET IN ANTIBODIES BY TYPE 2019-2027 ($ MILLION)
TABLE 5 CLINICALLY IMPORTANT MONOCLONAL
ANTIBODIES
TABLE 6 SECONDARY ANTIBODY SELECTIONS
TABLE 7 LATIN AMERICA IMMUNOHISTOCHEMISTRY
MARKET IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 8 LATIN AMERICA IMMUNOHISTOCHEMISTRY
MARKET IN REAGENTS BY TYPE 2019-2027 ($ MILLION)
TABLE 9 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 10 COMMON FIXATIVES AND THEIR GENERAL TARGET
ANTIGENS
TABLE 11 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
KITS 2019-2027 ($ MILLION)
TABLE 12 KIT COMPONENTS ARE AVAILABLE FOR IHC
OPTIMIZATION
TABLE 13 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY APPLICATION 2019-2027 ($ MILLION)
TABLE 14 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)
TABLE 15 SELECTED INFECTIOUS ETIOLOGIES OF
AUTOIMMUNE DISEASES
TABLE 16 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY END-USERS 2019-2027 ($ MILLION)
TABLE 17 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 LATIN AMERICA MARKET FOR
IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
FIGURE 2 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 3 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
IN ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 4 LATIN AMERICA ANTIBODIES MARKET IN PRIMARY
ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 5 LATIN AMERICA ANTIBODIES MARKET IN
SECONDARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 6 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
IN EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 7 LATIN AMERICA EQUIPMENT MARKET IN SLIDE
STAINING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 8 LATIN AMERICA EQUIPMENT MARKET IN TISSUE
MICROARRAYS 2019-2027 ($ MILLION)
FIGURE 9 LATIN AMERICA EQUIPMENT MARKET IN TISSUE
PROCESSING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 10 LATIN AMERICA EQUIPMENT MARKET IN SLIDE
SCANNERS 2019-2027 ($ MILLION)
FIGURE 11 LATIN AMERICA EQUIPMENT MARKET IN OTHER
EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 12 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
REAGENTS 2019-2027 ($ MILLION)
FIGURE 13 LATIN AMERICA REAGENTS MARKET IN HISTOLOGICAL
STAINS 2019-2027 ($ MILLION)
FIGURE 14 LATIN AMERICA REAGENTS MARKET IN BLOCKING
SERA AND REAGENTS 2019-2027 ($ MILLION)
FIGURE 15 LATIN AMERICA REAGENTS MARKET IN CHROMOGENIC
SUBSTRATES 2019-2027 ($ MILLION)
FIGURE 16 LATIN AMERICA REAGENTS MARKET IN FIXATION
REAGENTS 2019-2027 ($ MILLION)
FIGURE 17 LATIN AMERICA REAGENTS MARKET IN STABILIZERS
2019-2027 ($ MILLION)
FIGURE 18 LATIN AMERICA REAGENTS MARKET IN ORGANIC
SOLVENTS 2019-2027 ($ MILLION)
FIGURE 19 LATIN AMERICA REAGENTS MARKET IN PROTEOLYTIC
ENZYMES 2019-2027 ($ MILLION)
FIGURE 20 LATIN AMERICA REAGENTS MARKET IN DILUENTS
2019-2027 ($ MILLION)
FIGURE 21 PHASES OF HISTOLOGICAL STAINING
FIGURE 22 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
KITS 2019-2027 ($ MILLION)
FIGURE 23 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS
2019-2027 ($ MILLION)
FIGURE 24 LATIN AMERICA DIAGNOSTICS MARKET IN CANCER
2019-2027 ($ MILLION)
FIGURE 25 LATIN AMERICA DIAGNOSTICS MARKET IN
INFECTIOUS DISEASES 2019-2027 ($ MILLION)
FIGURE 26 LATIN AMERICA DIAGNOSTICS MARKET IN
CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)
FIGURE 27 LATIN AMERICA DIAGNOSTICS MARKET IN
AUTOIMMUNE DISEASES 2019-2027 ($ MILLION)
FIGURE 28 LATIN AMERICA DIAGNOSTICS MARKET IN DIABETES
MELLITUS 2019-2027 ($ MILLION)
FIGURE 29 LATIN AMERICA DIAGNOSTICS MARKET IN
NEPHROLOGICAL DISEASES 2019-2027 ($ MILLION)
FIGURE 30 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
DRUG TESTING 2019-2027 ($ MILLION)
FIGURE 31 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)
FIGURE 32 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
RESEARCH INSTITUTES 2019-2027 ($ MILLION)
FIGURE 33 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
OTHER END-USERS 2019-2027 ($ MILLION)
FIGURE 34 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 35 BRAZIL IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 36 HEALTHCARE SPENDING IN MEXICO 2014 AND 2040 ($
BILLION)
FIGURE 37 MEXICO IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 38 HEALTHCARE SPENDING IN ARGENTINA 2014 AND
2040 ($ BILLION)
FIGURE 39 ARGENTINA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 40 CHILE IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 41 HEALTHCARE EXPENDITURE IN CHILE 2005-2016
(PERCENTAGE SHARE OF GDP)
FIGURE 42 HEALTHCARE SPENDING IN CUBA (2014 AND 2040)
FIGURE 43 CUBA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($
MILLION)
FIGURE 44 REST OF LATIN AMERICA IMMUNOHISTOCHEMISTRY
MARKET 2019-2027 ($ MILLION)